|
| | Pamoic acid Basic information |
| | Pamoic acid Chemical Properties |
| Melting point | ≥300 °C (dec.) | | Boiling point | 434.1°C (rough estimate) | | density | 1.2472 (rough estimate) | | refractive index | 1.4593 (estimate) | | storage temp. | Sealed in dry,Room Temperature | | solubility | Soluble in nitrobenzene, pyridine | | form | Crystalline Powder | | pka | 2.67±0.30(Predicted) | | color | Yellow to yellow-green | | Water Solubility | PRACTICALLY INSOLUBLE | | Merck | 14,7005 | | BRN | 901319 | | InChIKey | WLJNZVDCPSBLRP-UHFFFAOYSA-N | | CAS DataBase Reference | 130-85-8(CAS DataBase Reference) | | EPA Substance Registry System | 2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy- (130-85-8) |
| | Pamoic acid Usage And Synthesis |
| Chemical Properties | Pamoic acid is yellow to yellow-green crystalline powder
| | Uses | Pamoic acid is used in preparation of repository derivatives of medicinal agents, used in pharmacology to increase the solubility of a drug in water. | | Uses | Agonist of the orphan G protein-coupled receptor GPR35: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activity. Used as an inhibitor in the real-time
fluorescence enzymatic characterization study of specialized human DNA polymerases. | | Definition | ChEBI: Pamoic acid is a dicarboxylic acid. It is functionally related to a 2-naphthoic acid. It is a conjugate acid of a pamoate(2-). | | General Description | Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. | | Safety Profile | Poison by intraperitoneal route. An eye irritant. When heated to decomposition it emits acrid smoke and irritating fumes. |
| | Pamoic acid Preparation Products And Raw materials |
|